Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice.

To study the contributions of insulin-dependent vs. insulin-independent mechanisms to intravenous glucose tolerance (K(G)), 475 experiments in mice were performed. An intravenous glucose bolus was given either alone or with exogenous insulin or with substances modulating insulin secretion and sensitivity. Seven samples were taken over 50 min. Insulin [suprabasal area under the curve (DeltaAUC(ins))] ranged from 0 to 100 mU. ml(-1). 50 min. After validation against the euglycemic hyperinsulinemic clamp, the minimal model of net glucose disappearance was exploited to analyze glucose and insulin concentrations to measure the action of glucose per se independent of dynamic insulin (S(G)) and the combined effect of insulin sensitivity (S(I)) and secretion. Sensitivity analysis showed that insulin [through disposition index (DI)] contributed to glucose tolerance by 29 +/- 4% in normal conditions. In conditions of elevated hyperinsulinemia, contribution by insulin increased on average to 69%. K(G) correlated with DI but was saturated for DeltaAUC(ins) above 15 mU. ml(-1). 50 min. Insulin sensitivity related to DeltaAUC(ins) in a hyperbolic manner, whereas S(G) did not correlate with the insulin peak in the physiological range. Thus glucose tolerance in vivo is largely mediated by mechanisms unrelated to dynamic insulin and saturates with high insulin.

[1]  D. Finegood,et al.  Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat. , 1999, American journal of physiology. Endocrinology and metabolism.

[2]  B. Ahrén,et al.  Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women , 2000, Diabetologia.

[3]  G F Cahill,et al.  Brain metabolism during fasting. , 1967, The Journal of clinical investigation.

[4]  M. Magnuson,et al.  Effects of Increased Glucokinase Gene Copy Number on Glucose Homeostasis and Hepatic Glucose Metabolism* , 1997, The Journal of Biological Chemistry.

[5]  Petre Stoica,et al.  Decentralized Control , 2018, The Control Systems Handbook.

[6]  D. S. Amatuzio,et al.  Interpretation of the rapid intravenous glucose tolerance test in normal individuals and in mild diabetes mellitus. , 1953, The Journal of clinical investigation.

[7]  L. Mandarino,et al.  Dose-response characteristics for effects of insulin on production and utilization of glucose in man. , 1981, The American journal of physiology.

[8]  R. DeFronzo,et al.  Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. , 1989, The American journal of physiology.

[9]  B. Ahrén,et al.  Cholecystokinin and the regulation of insulin secretion. , 1992, Scandinavian journal of gastroenterology.

[10]  D. Schuster,et al.  Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants. , 1996, The American journal of the medical sciences.

[11]  Giovanni Pacini,et al.  Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. , 1997, American journal of physiology. Endocrinology and metabolism.

[12]  Giovanni Pacini,et al.  Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. , 1998, American journal of physiology. Endocrinology and metabolism.

[13]  R N Bergman,et al.  Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components. , 1997, The Journal of clinical investigation.

[14]  R. Bergman Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[15]  C. Rantzau,et al.  Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI. , 1995, The American journal of physiology.

[16]  B. Ahrén Insulinotropic action of truncated glucagon-like peptide-1 in mice. , 1995, Acta physiologica Scandinavica.

[17]  R N Bergman,et al.  Importance of Glucose Per Se to Intravenous Glucose Tolerance: Comparison of the Minimal-Model Prediction with Direct Measurements , 1985, Diabetes.

[18]  D. Finegood,et al.  Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. , 1996, The American journal of physiology.

[19]  G. Pacini,et al.  Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice. , 1999, American journal of physiology. Endocrinology and metabolism.

[20]  B. Ahrén,et al.  Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells. , 1996, Endocrinology.

[21]  R N Bergman,et al.  The Contribution of Insulin-Dependent and Insulin-Independent Glucose Uptake to Intravenous Glucose Tolerance in Healthy Human Subjects , 1994, Diabetes.

[22]  W. Noonan,et al.  Renal Function and Glucose Transport in Male and Female Mice with Diet-Induced Type II Diabetes Mellitus (44568) , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[24]  D. Finegood,et al.  Minimal-model estimates of insulin sensitivity are insensitive to errors in glucose effectiveness. , 2000, The Journal of clinical endocrinology and metabolism.

[25]  R N Bergman,et al.  Role of Glucose Effectiveness in the Determination of Glucose Tolerance , 1996, Diabetes Care.

[26]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[27]  F. Sundler,et al.  GLP‐1 and GLP‐17‐36 Amide: Influences on Basal and Stimulated Insulin and Glucagon Secretion in the Mouse , 1991, Pancreas.

[28]  G. Pacini,et al.  PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. , 1998, American journal of physiology. Endocrinology and metabolism.

[29]  S E Kahn,et al.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. , 1996, The Journal of clinical investigation.

[30]  B. Ahrén,et al.  Ca2+-independent phospholipase A2 contributes to the insulinotropic action of cholecystokinin-8 in rat islets: dissociation from the mechanism of carbachol. , 1998, Diabetes.

[31]  H. Meissner,et al.  Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells. , 1982, Biochemical pharmacology.